PHEN Clinical Trials Learning Session Presented in Collaboration with Pfizer The Prostate Health Education Network (PHEN), in collaboration with Pfizer, recently hosted a Clinical Trials Learning Session focused on emerging research in metastatic castration-resistant prostate cancer (mCRPC). The program highlighted three coordinated Phase 3 clinical studies evaluating an investigational twice-daily oral EZH2 inhibitor in combination […]
